Scored Patient-Generated Subjective Global Assessment© (PG-SGA),

PG-SGA Short Form© (PG-SGA SF) and the Pt-Global© Multilingual Research and Clinical app

Permission Request Form

Personal Information (person requesting permission, principal investigator)

Name:

Title:

Organization:

Address:
Country:

Phone:

Fax:

Email:

Date of completing this form (dd-mm-yy):

1. Purpose for the use of the PG-SGA:

Electronic Medical/Health Record, please specify: ______

Education

Health practice internal study

Research:
Clinical trial (circle): Phase I Phase II Phase III

Observational research initiative - please specify: ______

Psychological Intervention

Symptom Management

Other, please specify: ______

Publication, please specify: ______

Other, please specify: ______

2. Title of Project/Publication:

3. Please give a concise overview of the project, describing the Aim/Objective, Study Design, Methods and other relevant information:

4. Version and language of PG-SGA to be used:

a. Version:
PG-SGA full version, please specify version date: ______

PG-SGA Short Form, please specify version date: ______

Pt-Global app/web tool

b. Language version of PG-SGA to be used:

English metric
English non-metric
Dutch
Portuguese

Thai
Other (please specify language): ______

5. Method of completing the PG-SGA in the project:

Patient completes Boxes 1 – 4

Patient completes Boxes 1 – 4 and health care professional completes Worksheets 1 – 5

Health care professional completes Boxes 1 – 4 and Worksheets 1 – 5

6. If you have already done the research, did you make any modifications on the PG-SGA form? If so, please specify.
No
Yes, I made the following changes: ______

7. Funding source, if applicable:

8. Expected or actual study start date (dd-mm-yy):

9. Expected or actual study end date (dd-mm-yy):

10. Scheduled number of PG-SGAs per patient: ______

11. Please specify assessment schedule, if greater than 1:

Weekly

Monthly

Bi-monthly

Quarterly

Semi-annually

Annually

Other please specify: ______

12. Total number of expected or actual patients:

13. Patient inclusion (diagnosis and stage type):

14. Type of organization:

Academic Institution

Continuing Education Provider

Clinic

Medical Communications Firm

Outcomes Research Organization

Pharmaceutical Firm

Private Practice

Publisher

Other, please specify:______

15. Have you written any abstracts or manuscripts etc. including the use of the PG-SGA?

Yes
No

If yes, please list title of each publication and send copies to the address below.

1. ______

2. ______

3. ______

If you need permission from Pt-Global beyond email notification, please include information regarding to whom the permission letter should be addressed.

Name:

Title:

Organization:

Address:

Phone:

Fax:

Email:

Faith D. Ottery, MD, PhD, FACN

Ottery & Associates, LLC.

1145 Museum Blvd, #411

Vernon Hills, IL 60061

Phone +001-215-694-1600

V0.8.2018